Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 Next >
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Biotech and Pharmaceuticals Earnings Business News
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Novo Nordisk A/S Science LILLY DRN
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Constellation Brands Inc Business News General Motors Co
From CNBC.com News
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
Tags Breaking News: Technology Health & Science Hospitals
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Amazon/com Inc Merck & Co Inc LILLY DRN
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Business News Biotechnology LILLY DRN
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags LILLY DRN CVS Health Corp Health care industry
From CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Tags Pfizer Inc Health care industry Pharmaceuticals
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Pharmaceuticals Breaking News: Davos World economy
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags JPMorgan Chase & Co Amazon/com Inc NVIDIA Corp
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags US: News Ironwood Pharmaceuticals Inc Breaking News: Business
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Business News Biotechnology LILLY DRN
From CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
Tags LILLY DRN Merck & Co Inc Business News
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Waystar Holding Corp Accolade Inc Health care industry
From CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Tags Earnings Business News LILLY DRN
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Health care industry Health & Science Business
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Business Health & Science Labor economy
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Business Social issues Health & Science
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Health & Science Social issues Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: Uber is a buy
Tags Stock markets Investing S&P 500
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Health care costs Business Health & Science
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Biotechnology Business News LILLY DRN
From CNBC.com News
5 things to know before the stock market opens Friday
Tags 5 Things to Know Investment strategy Nike Inc
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Tags Breaking news Biotech and Pharmaceuticals Social issues
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Biotech and Pharmaceuticals Healthy Returns Novo Nordisk A/S
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Amazon/com Inc Biotech and Pharmaceuticals US: News
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Health & Science Crime Obesity
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags GE HealthCare Technologies Inc Healthy Returns LILLY DRN
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.